Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma
Lemeng Sun(First Bethune Hospital of Jilin University), Jiuwei Cui(Jilin University)
Cited by 31
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
|Biomarker Research|2020|473
Mechanisms of Cancer Resistance to Immunotherapy
|Frontiers in Oncology|2020|346
Distinct biological effects of low-dose radiation on normal and cancerous human lung cells are mediated by ATM signaling
|Oncotarget|2016|27
Expert consensus on treatment for stage III non‐small cell lung cancer
|Medicine Advances|2023|18